AzTrials
AzTrials

Risk ReductionPHASTTNCT03109899

Personalized HIV and STI Testing Tool

A study testing Sex Pro mobile Application in people with Risk Reduction and HIV, run by Public Health Foundation Enterprises, Inc. at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The PHASTT Study is focused on understanding of facilitators and barriers to mHealth use among young Black men who have sex with men (MSM), and testing a novel mobile app to increase HIV/STI testing and PrEP uptake. Read more about this study

Who is it for?
Ages 18 to 29 years, men onlyHealthy volunteers can take part
What is being tested?
Sex Pro mobile Application
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteUnited States
Study dates
18 Sep 2019to Jan 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 29 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Self-identify as Black.
  • Self-report being HIV negative.
  • Report anal sex with at two or more male sex partners in the prior 12 months.
  • Own an iOS or Android mobile phone.
  • Willing and able to give written informed consent to participate in all activities outlined by the protocol.

Who cannot join

  • Inadequate contact information for follow-up
  • In a mutually monogamous sexual relationship for the past 12 months
  • Currently taking PrEP
  • Does not have reliable access to the internet
  • Does not live, work or play in the San Francisco Bay Area
  • Currently enrolled in another HIV intervention study
  • Prior enrollment in an HIV vaccine trial with receipt of experimental vaccine product
  • Any medical, psychiatric, or social condition, or occupational, or other responsibility that, in the judgment of the investigator, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.

Trial locations and contacts

1 site in 1 country.

Kenneth Coleman, MA contact

628-217-7443

kenneth.coleman@sfdph.org

Hyman Scott, MD, MPH contact

628-217-7483

hyman.scott@sfdph.org

United States1 site, 1 recruiting
  • Bridge HIV, San Francisco Department of Public Health

    San Francisco, California, 94102

    Hyman Scott, MD, MPH

    Recruiting

Other trials in United States

About this study

Official title: Randomized, Controlled Trial of the Sex Pro Mobile App for Young Black MSM in San Francisco and Oakland, CA

The PHASTT Study is focused on understanding of facilitators and barriers to mHealth use among young Black men who have sex with men (MSM), and testing a novel mobile app to increase HIV/STI testing and PrEP uptake.

Read the detailed description

The Sex Pro mobile application (app) being tested facilitates home HIV-testing, home sexually transmitted infection (STI) test self-collection, and pre-exposure prophylaxis (PrEP) uptake. The app integrates a personalized HIV risk assessment with home HIV and STI testing options for young, Black MSM.

Being tested
Sex Pro mobile Application
Keywords
mHealth, HIV Prevention
Medical subject headings
Risk Reduction Behavior, Sexually Transmitted Diseases, Hepatitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sex Pro mobile ApplicationBehavioural

    Mobile mHealth app that provides HIV risk assessment, home HIV/STI testing options, and PrEP uptake support for young Black MSM.

Study groups in NCT03109899
Study groupRoleWhat they receive
InterventionExperimentalParticipants in this arm will have access to the Sex Pro mobile app and support for HIV/STI testing and PrEP uptake.
Receives: Behavioral: Sex Pro mobile Application
ControlNo interventionParticipants in this arm will be given the local standard of care for HIV/STI testing and PrEP access.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The feasibility and acceptability of Sex Pro to increase HIV/STI testing and PrEP uptake among young Black MSM.

    As measured via computer assisted interview (CASI)

    Measured: 9 months

Secondary outcomes (4)
  1. The rate of HIV testing in the Sex Pro mobile application intervention versus control arms.

    As measured by CASI

    Measured: 9 months

  2. The rate of STI testing in the Sex Pro mobile application intervention versus control arms.

    As measured by CASI

    Measured: 9 months

  3. The rate of PrEP uptake in the Sex Pro mobile application intervention versus control arms.

    As measured by pharmacy confirmation

    Measured: 9 months

  4. Changes in sexual risk behaviors among young Black MSM in the Sex Pro mobile application intervention vs. control arms

    As measured via CASI

    Measured: 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Apr 2017
  2. Study start18 Sep 2019
  3. Primary completionJan 2021 (estimated)
  4. Study completionJan 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03109899
Sponsor's protocol ID
17-22103
Other IDs
5K23MH104116
Acronym
PHASTT
Status last verified
Feb 2020
First submitted
29 Mar 2017
Last updated
20 Feb 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Sex Pro mobile Application in people with Risk Reduction and HIV, run by Public Health Foundation Enterprises, Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Kenneth Coleman, MA (628-217-7443, kenneth.coleman@sfdph.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The feasibility and acceptability of Sex Pro to increase HIV/STI testing and PrEP uptake among young Black MSM. (time frame: 9 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in